IP Library Granted Patent US 9,227,017
Granted Patent B2
US 9,227,017 · App. 13/529,757 · Granted Jan 5, 2016

Automatic mixing device and delivery system

Inventors: Brent Alan Buchine (Watertown, MA); Christopher John Stepanian (Somerville, MA); Ralph Navarro (Shrewsbury, MA); Adam Richard Standley (Boston, MA)
Assignee: Windgap Medical, LLC
A61M5/2066A61J1/2093A61M5/2033A61M5/2448B65B29/10A61M2005/2073
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,227,017
App. No.
13/529,757
Granted
Jan 5, 2016
Kind
B2
Abstract

A wet/dry auto-mixing injector having a mixing device containing at least one microfluidic channel for mixing or dissolving a dry component with a wet component stored in the injector device.

Claims (27)

1. A medicament mixing device comprising:

a housing assembly having at least one interior chamber, the interior chamber including a wet compartment containing a wet medicament component;

a seal structure placed within the wet compartment at an outlet orifice of the interior chamber, the seal structure being initially in a sealing condition that maintains the wet medicament component within the interior chamber, the seal structure being converted to a mixing condition as a result of activation of the device;

a mixing assembly comprised of at least one microfluidic channel, in fluid communication with the interior chamber when the device is activated, the at least one microfluidic channel a) having a non-randomized predefined sidewall or b) providing a singular predefined flow path; and

wherein a portion of the mixing assembly contains a dry medicament component within the at least one microfluidic channel, the dry medicament component configured to mix with the wet medicament component when the seal structure is converted to the mixing condition.

2. The mixing device of claim 1 , further including internal structures contained within the microfluidic channel.

3. An automatic injection device containing a pre-loaded charge of medicament for automatically self-administering the medicament upon actuation thereof, the device comprising:

a housing assembly having an interior chamber, the interior chamber including a wet compartment containing a wet medicament component;

a seal structure placed within the wet compartment at an outlet orifice of the interior chamber, the seal structure being initially in a sealing condition that maintains the wet medicament component within the interior chamber, the seal structure being converted to a mixing condition as a result of activation of the device;

a mixing assembly comprised of at least one microfluidic channel, the at least one microfluidic channel a) having a non-randomized predefined sidewall or b) providing a singular predefined flow path, the microfluidic channel being in fluid communication with the interior chamber when the device is activated, and wherein the mixing assembly contains a dry medicament component contained within the at least one microfluidic channel configured to mix with the wet medicament component when the seal structure is converted to the mixing condition;

a delivery assembly that dispenses a charge of medicament comprised of the mixed wet medicament component and the dry medicament component from the housing assembly;

an activation assembly carried by the housing assembly and including a stored energy source, wherein activation of the activation assembly releases the stored energy from the stored energy source, and wherein the release of the stored energy causes a) the seal structure to be converted from the sealing condition to the mixing condition and thereby permit the wet medicament component to pass there through, b) the wet medicament component to be forced through the mixing assembly to facilitate mixing of the wet and dry medicament components thus forming the charge of medicament, and c) the charge of medicament to be forced through the delivery assembly.

4. The automatic injection device of claim 3 , wherein the dry medicament component is partially soluble in the wet medicament component.

5. The automatic injection device of claim 3 , wherein the microfluidic channel of the mixing device includes a plurality of grooves formed therein, wherein said grooves facilitate chaotic flow when a wet component flows by said grooves.

6. The automatic injection device of claim 3 , wherein the one or more microfluidic channels of the mixing assembly include a plurality of bends.

7. The automatic injection device of claim 3 , wherein the microfluidic channel of the mixing device includes internal structures.

8. The automatic injection device of claim 3 , further including a homogenizing region in fluid communication with, and having a larger cross section than, the mixing assembly.

9. The automatic injection device of claim 3 , wherein the dry medicament component contained within a portion of the one or more microfluidic channels contain a lyophilized dry medicament.

10. The automatic injection device of claim 9 , wherein the lyophilized dry medicament is an epinephrine component or any salt-based form thereof.

11. The automatic injection device of claim 3 , wherein the mixing assembly includes two or more microfluidic channels.

12. The automatic injection device of claim 3 , further including a safety cap removably inserted into the housing assembly, wherein the device may not be activated until the safety cap is removed from the housing assembly.

13. The automatic injection device of claim 3 , wherein the stored energy source is a compressed spring.

14. The automatic injection device of claim 3 , wherein the interior chamber is configured to collapse upon activation.

15. The automatic injection device of claim 3 , further including a trigger assembly configured to release the stored energy source when activated.

16. The automatic injection device of claim 3 , wherein a cross-section of the one or more microfluidic channels is less than two millimeters across in one dimension.

17. The automatic injection device of claim 3 , wherein a cross-section of the one or more microfluidic channels is less than one millimeter across in one dimension.

18. The automatic injection device of claim 3 , wherein no dimension of a cross-section of the one or more microfluidic channels is greater than a millimeter across.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2025
From: WINDGAP MEDICAL, INC.
To: WINDGAPLEGACYCO, LLC
Reel/Frame 071907/0607 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 18, 2013
From: NAVARRO, RALPH; BUCHINE, BRENT A; STEPANIAN, CHRISTOPHER J; STANDLEY, ADAM
To: WINDGAP MEDICAL, INC.
Reel/Frame 030637/0099 →
Continuity (3)
Provisional Application 61499676 · Jun 21, 2011
Provisional Application 61597161 · Feb 9, 2012
Related Publication 20130178823A1 · Jul 11, 2013